CTVA vs EBS
Corteva Inc (CTVA) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Corteva Inc (CTVA) is a agricultural inputs company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CTVA revenue for 2024-12-31 was $16.91B. Net income was $919.0M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
CTVA currently screens at market cap $51.52B and trailing P/E 41.6. EBS currently screens at market cap $416.4M.
Not investment advice. Open the CTVA and EBS stock pages for the full models.
Not investment advice.